RIGEL PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Assets
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-03
- RIGEL PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $56.00K, a 49.09% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2023-12-31 was $110.00K.
- RIGEL PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2023-09-30 was $22.00K, a 89.62% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2023-06-30 was -$51.00K.
- RIGEL PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- RIGEL PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2024 was $79.00K.
- RIGEL PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2023 was -$266.00K, a 292.75% decline from fiscal 2022.
- RIGEL PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2022 was $138.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-03 | |||
| 2024-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $79.00K 10-K · filed 2026-03-03 | ||
| 2024-09-30 | $23.00K 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $132.00K derived: sum of 2 quarters · filed 2026-03-03 | $81.00K derived: sum of 3 quarters · filed 2026-03-03 | -$266.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$29.00K derived: sum of 2 quarters · filed 2024-11-07 | -$376.00K 10-Q · filed 2024-11-07 | -$703.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | -$51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$398.00K 10-Q · filed 2024-08-06 | -$725.00K derived: sum of 3 quarters · filed 2025-03-04 | -$513.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | -$347.00K 10-Q · filed 2024-05-07 | -$674.00K derived: sum of 2 quarters · filed 2025-03-04 | -$462.00K derived: sum of 3 quarters · filed 2025-03-04 | |
| 2022-12-31 | -$327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$115.00K derived: sum of 2 quarters · filed 2025-03-04 | $138.00K 10-K · filed 2025-03-04 | |
| 2022-09-30 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $465.00K 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $253.00K 10-Q · filed 2023-08-01 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $732.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $732.00K 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $732.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $732.00K 10-Q · filed 2018-05-01 | |||
| 2016-12-31 | $88.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $55.00K derived: sum of 2 quarters · filed 2018-03-06 | $57.00K 10-K · filed 2018-03-06 | |
| 2015-09-30 | $55.00K 10-Q · filed 2016-11-01 | $57.00K 10-Q · filed 2016-11-01 | ||
| 2014-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $96.00K derived: sum of 2 quarters · filed 2017-03-07 | $98.00K 10-K · filed 2017-03-07 | |
| 2014-09-30 | $44.00K 10-Q · filed 2015-11-03 | $46.00K 10-Q · filed 2015-11-03 | ||
| 2013-12-31 | $16.00K 10-K · filed 2016-03-08 | |||
| 2012-12-31 | $17.00K 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |